Avelumab Prolongs Survival in Advanced Urothelial Cancer

MONDAY, Sept. 21, 2020 — Avelumab added to best supportive care prolongs survival for patients with unresectable local advanced or metastatic urothelial cancer, according to a study published online Sept. 18 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the…

Racial disparity in prostate cancer survival tied to region

(HealthDay)—National, race-based differences in prostate cancer survival are due to regional variation, even for low-risk prostate cancer, according to a study published online March 31 in JAMA Network Open. Sean A. Fletcher, M.D., from Brigham and Women’s Hospital in Boston, and colleagues analyzed data from 17 geographic registries within the…

Brachytherapy boost ups survival in locally advanced cervical cancer

(HealthDay)—The current standard of care (SOC) for advanced cervical cancer—external beam radiation therapy (EBRT) and chemotherapy in combination with brachytherapy—provides significantly higher overall survival over chemoradiation alone; however, not all women are receiving brachytherapy, according to a study presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer,…